ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ValenzaBio Partners with ProBioGen to Maximize Cell Line Productivity and Licenses GlymaxX®
July 28, 2021ProBioGen and ValenzaBio today jointly announced the initiation of a cell line development project involving the application of ProBioGen's proprietary GlymaxX technology. -
ProBioGen Inks Next Commercial GlymaxX® License with Roche
January 16, 2020ProBioGen AG has signed a commercial license agreement with Roche for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody’s ADCC anti-tumor activity. -
ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
May 24, 2019ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
Pharma Sources Insight January 2025
